Clinical Edge Journal Scan

Resistance training reduces HbA1c levels in patients with T2D


 

Key clinical point: Resistance training (RT) effectively reduces glycosylated hemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2D), with RT interventions triggering a larger vs. medium or smaller improvement in muscular strength leading to a greater reduction in HbA1c.

Major finding: RT intervention vs. control treatment significantly decreased HbA1c (weighted mean difference −0.39; P < .001), with a larger vs. medium or small effect on muscular strength leading to a greater reduction in HbA1c (β −0.99; P = .0470).

Study details: Findings are from a meta-analysis of 20 trials including 1172 patients with T2DM.

Disclosures: The study received no specific funding. The authors declared no competing interests.

Source: Jansson AK et al. Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2022;10:e002595 (Mar 10). Doi: 10.1136/bmjdrc-2021-002595

Recommended Reading

Below the belt: sexual dysfunction overlooked in women with diabetes
Type 2 Diabetes ICYMI
Cannabis exposure in pregnancy linked with childhood obesity
Type 2 Diabetes ICYMI
SCORED: Sotagliflozin shows robust MACE benefit
Type 2 Diabetes ICYMI
New HF guidelines feature ‘quad’ therapy, tweaked terminology
Type 2 Diabetes ICYMI
Novel tool could calculate CVD risk in T2DM
Type 2 Diabetes ICYMI
Could AI tool identify type 1 diabetes earlier in childhood?
Type 2 Diabetes ICYMI
Type 2 diabetes remission possible for those with lower BMI
Type 2 Diabetes ICYMI
Dapagliflozin shows promise in young people with T2D in phase 3
Type 2 Diabetes ICYMI
T2D: Empagliflozin improves cognitive and physical function in older adults with HFpEF
Type 2 Diabetes ICYMI
Fenofibrate improves heart failure outcomes in patients with T2D treated with simvastatin
Type 2 Diabetes ICYMI